» Articles » PMID: 21896284

Tonic and Phasic Release of Glutamate and Acetylcholine Neurotransmission in Sub-regions of the Rat Prefrontal Cortex Using Enzyme-based Microelectrode Arrays

Overview
Specialty Neurology
Date 2011 Sep 8
PMID 21896284
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The medial prefrontal cortex (mPFC) is an area of the brain critical for higher cognitive processes and implicated in disorders of the CNS such as drug addiction, depression and schizophrenia. Glutamate and acetylcholine are neurotransmitters that are essential for cortical functioning, yet little is known about the dynamic function of these neurotransmitters in subregions of the mPFC. In these studies we used a novel microelectrode array technology to measure resting levels (tonic release) of glutamate and acetylcholine as well as KCl-evoked release (stimulated phasic release) in the mPFC of the anesthetized rat to further our understanding of both tonic and phasic neurotransmission in the cingulate cortex, prelimbic cortex, and infralimbic cortex of the mPFC. Studies revealed homogeneity of tonic and phasic signaling among brain subregions for each neurotransmitter. However, resting levels of glutamate were significantly higher as compared to acetylcholine levels in all subregions. Additionally, KCl-evoked acetylcholine release in the cingulate cortex (7.1 μM) was significantly greater than KCl-evoked glutamate release in any of the three subregions (Cg1, 2.9 μM; PrL, 2.0 μM; IL, 1.8 μM). Interestingly, the time for signal decay following KCl-evoked acetylcholine release was significantly longer by an average of 240% as compared to KCL-evoked glutamate release for all three brain subregions. Finally, we observed a negative relationship between acetylcholine resting levels and KCl-evoked release in the Cg1. These data suggest a homogenous distribution of both glutamatergic and acetylcholinergic innervation in the mPFC, with alterations in tonic and phasic release regulation accounting for differences between these neurotransmitters.

Citing Articles

Recent Progress in Flexible Microelectrode Arrays for Combined Electrophysiological and Electrochemical Sensing.

Siwakoti U, Jones S, Kumbhare D, Cui X, Castagnola E Biosensors (Basel). 2025; 15(2).

PMID: 39997002 PMC: 11853293. DOI: 10.3390/bios15020100.


Cortico-striatal action control inherent of opponent cognitive-motivational styles.

Avila C, Sarter M Elife. 2025; 13.

PMID: 39968969 PMC: 11839163. DOI: 10.7554/eLife.100988.


Cortico-striatal action control inherent of opponent cognitive-motivational styles.

Avila C, Sarter M bioRxiv. 2024; .

PMID: 38559086 PMC: 10979997. DOI: 10.1101/2024.03.12.584623.


Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity.

Pinky P, Bloemer J, Smith W, Du Y, Heslin R, Setti S Cells. 2023; 12(21).

PMID: 37947603 PMC: 10648717. DOI: 10.3390/cells12212525.


A neural probe for concurrent real-time measurement of multiple neurochemicals with electrophysiology in multiple brain regions in vivo.

Chae U, Woo J, Cho Y, Han J, Yang S, Yang E Proc Natl Acad Sci U S A. 2023; 120(28):e2219231120.

PMID: 37399389 PMC: 10334791. DOI: 10.1073/pnas.2219231120.


References
1.
Hara K, Harris R . The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels. Anesth Analg. 2002; 94(2):313-8, table of contents. DOI: 10.1097/00000539-200202000-00015. View

2.
Crook J, Tomaskovic-Crook E, Copolov D, Dean B . Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry. 2001; 158(6):918-25. DOI: 10.1176/appi.ajp.158.6.918. View

3.
Meyer Jr E, Engel D, Cooper J . Acetylation and phosphorylation of choline following high or low affinity uptake by rat cortical synaptosomes. Neurochem Res. 1982; 7(6):749-59. DOI: 10.1007/BF00965527. View

4.
Sofuoglu M, Mooney M . Cholinergic functioning in stimulant addiction: implications for medications development. CNS Drugs. 2009; 23(11):939-52. PMC: 2778856. DOI: 10.2165/11310920-000000000-00000. View

5.
Miele M, Berners M, Boutelle M, Kusakabe H, Fillenz M . The determination of the extracellular concentration of brain glutamate using quantitative microdialysis. Brain Res. 1996; 707(1):131-3. DOI: 10.1016/0006-8993(95)01371-7. View